
    
      Patients 18 years and older, diagnosed with any cancer, that is losing weight and have
      anorexia will be selected. They must have normal levels of creatinine, thyroid evaluation and
      hepatic function. If they are taking corticosteroid, they must keep losing weight and refer
      anorexia, as well as if they are on treatment with chemotherapy.

      Patients will receive 50mg of the guaraná twice daily for 4 weeks. Every week will be an
      evaluation of the weight, level of appetite and answer 2 questionaries of quality of life and
      level of symptoms (FACT-G and MDASI).

      This is a fase II study, open-label, no randomized, with two steps following ¨two stages of
      Simon¨ model. First step 18 patients will be included and if there are 3 good responses
      second step will follow, including 17 more patients. Response will be considered if there is
      at least 5% of gain in the weight.
    
  